首页> 外文会议>NATO Advanced Research Workshop on Functional Nanostructures and Sensors for CBRN Defence and Environmental Safety and Security >Synthesis of PLGA-PEG-PLGA Polymer Nano-Micelles - Carriers of Combretastatin-Like Antitumor Agent 16Z
【24h】

Synthesis of PLGA-PEG-PLGA Polymer Nano-Micelles - Carriers of Combretastatin-Like Antitumor Agent 16Z

机译:PLGA-PEG-PLGA聚合物纳米胶束的合成 - 类似物的抗肿瘤剂16Z的载体

获取原文

摘要

One of the most important tendencies for the development of modern chemistry is related to the new trends in biomedicine and pharmacy. Today, significant advances have been made in the development of biodegradable and biocompatible polymer materials and the synthesis of corresponding polymer nano-micelles. In this work we aimed to synthesize new biodegradable and biocompatible block copolymers based on poly(lactide-co-glycolide) (PLGA) and poly (ethylene glycol) (PEG) with linear (ABA-type) architecture, to investigate their ability to form nanosized micelles and its aptitude to acts as carriers of combretastatin-like antitumor agents. The synthesis of linear PLGA_(1000)-PEG_(1000)-PLGA_(1000) block copolymer was carried out in line with standard procedures. The size and morphology of the obtained micelles were determined by transmission electron microscopy (TEM) and dynamic light scattering (DLS). The capability of obtained micelles to adsorb and deliver combretastatin-like antitumor agents into living cells was also demonstrated. We showed that the obtained copolymers formed nanosized micelles with the combretastatin-like antitumor agent 16Z. In vitro biocompatibility results denote that all tested blank-nano-micelles are devoid of cytotoxic effects and may be used as non-toxic drug carriers to target cells. Cellular uptake of 16Z-loaded PLGA_(1000)-PEG_(1000)-PLGA_(1000) micelles by HepG2 cells showed continuous uptake up to 72 h and a delay in the cytotoxic effect of 16Z. In an attempt to design new biomimetic analogs of natural combretastatin A-4 (CA-4) and its synthetic amino- derivatives, we selected benzothiazolone heterocycles as a scaffold for a bioisosteric replacement. In silico, drug-likeness and toxicity predictions showed better properties of benzothioazolone CA-4 analogs. The obtained results are very promising and need future detailed investigations.
机译:现代化学发展最重要的趋势之一与生物医学和药房的新趋势有关。如今,在可生物降解和生物相容性聚合物材料的发展和相应的聚合物纳米胶束的合成方面取得了显着的进展。在这项工作中,我们旨在将基于聚(丙交酯 - 共糖苷)(PLGA)和聚(乙二醇)(PEG)的新的可生物降解和生物相容性嵌段共聚物用线性(ABA型)架构,以研究其形成的能力纳米化胶束及其作为携带型抗肿瘤剂的载体的衔接性。线性PLGA_(1000)-PEG_(1000)-PLGA_(1000)嵌段共聚物的合成是以标准方法进行的。通过透射电子显微镜(TEM)和动态光散射(DLS)测定所得胶束的尺寸和形态。还证明了所得胶束吸附和将抗组蛋白样抗肿瘤剂进入活细胞的能力。我们表明,所得共聚物形成纳米化胶束与混合蛋白样抗肿瘤剂16z。体外生物相容性结果表示所有测试的漂白米细胞缺乏细胞毒性作用,并且可以用作靶细胞的无毒药物载体。 HepG2细胞的16z加载PLGA_(1000)-PEG_(1000)-PEG_(1000)-PLGA_(1000)胶束的蜂窝摄取显示连续摄取至72小时,延迟为16Z的细胞毒性效果。在尝试设计新的天然组合A-4(CA-4)和合成氨基衍生物的新型生物摩擦类似物,我们选择苯并噻唑酮杂环作为生物替代品的支架。在硅藻中,药物似的性和毒性预测表明苯并噻唑酮Ca-4类似物的更好性。获得的结果非常有希望,需要未来的详细调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号